1025717-56-9

Basic information

• Product Name: 3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)-N-(3,4-dihydro-3-oxo-2H-benzo[b][1,4]oxazin-6-yl)-4-methylbenzamide trifluoroacetate
• Synonyms: 3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)-N-(3,4-dihydro-3-oxo-2H-benzo[b][1,4]oxazin-6-yl)-4-methylbenzamide trifluoroacetate
• CAS NO: 1025717-56-9
• Molecular Weight: 566.496
• Mol File: 1025717-56-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)-N-(3,4-dihydro-3-oxo-2H-benzo[b][1,4]oxazin-6-yl)-4-methylbenzamide trifluoroacetate(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)-N-(3,4-dihydro-3-oxo-2H-benzo[b][1,4]oxazin-6-yl)-4-methylbenzamide trifluoroacetate(1025717-56-9)
• EPA Substance Registry System: 3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)-N-(3,4-dihydro-3-oxo-2H-benzo[b][1,4]oxazin-6-yl)-4-methylbenzamide trifluoroacetate(1025717-56-9)

Safety Data

• Hazardous Substances Data: 1025717-56-9(Hazardous Substances Data)

Upstream product

• 641569-94-0 4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}benzoic acid 
• 89976-75-0 6-amino-2H-1,4-benzoxazin-3(4H)-one 

Relevant articles and documents

COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to beat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of c-kit, PDGFRα and PDGFRβ kinases. Formula (I).